No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample

Tim Moons, Marc De Hert, Gunther Kenis, Wolfgang Viechtbauer, Jim van Os, Henning Gohlke, Stephan Claes, Ruud van Winkel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)951-962
JournalPharmacogenomics
Volume15
Issue number7
DOIs
Publication statusPublished - May 2014

Keywords

  • antipsychotic
  • genetic variation
  • IGF
  • insulin growth factor
  • metabolic syndrome
  • methylation
  • schizophrenia

Cite this